Mark A. Murakami

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Alessandro Pastore, Vindi Jurinović, Robert Kridel et al. · The Lancet Oncology · 2015 · 613 citations

Medicine, Immunology, Oncology +17

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

Elizabeth C. Townsend, Mark A. Murakami, Alexandra Christodoulou et al. · Cancer Cell · 2016 · 304 citations · Full text

Medicine, Biomedical Sciences, Drug Discovery +6

Distinction of lymphoid and myeloid clonal hematopoiesis

Abhishek Niroula, Aswin Sekar, Mark A. Murakami et al. · Nature Medicine · 2021 · 298 citations · Full text

Medicine, Cell Biology, Hematology +12

High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arrays

Nathan Cermak, Selim Olçum, Francisco Feijó Delgado et al. · Nature Biotechnology · 2016 · 236 citations

Engineering, Bioengineering, Biological Engineering +16

Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis

David S. Grenda, Mark A. Murakami, Jhuma Ghatak et al. · Blood · 2007 · 204 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14